Bayraktar, Ulas D <br/><br/>
Fifty years of melphalan use in hematopoietic stem cell transplantation.  [electronic resource] 

 -  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation  Mar 2013 
 - 344-56 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1523-6536 
<br/><br/><label>Standard No.: </label>10.1016/j.bbmt.2012.08.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine Nucleotides--administration & dosage<br/>Alemtuzumab<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols<br/>Arabinonucleosides--administration & dosage<br/>Boronic Acids--administration & dosage<br/>Bortezomib<br/>Clofarabine<br/>Graft Survival--drug effects<br/>Hematologic Neoplasms--immunology<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Lenalidomide<br/>Melphalan--pharmacology<br/>Multiple Myeloma--immunology<br/>Myeloablative Agonists--pharmacology<br/>Pyrazines--administration & dosage<br/>Thalidomide--administration & dosage<br/>Transplantation Conditioning--methods<br/>Transplantation, Autologous<br/>Transplantation, Homologous